Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 75,787,342
- Total 13F value
- $84,752,627
- Share change
- +639,147
- Put/Call ratio
- 3.6%
- SEC-reported price per share
- $1.12
- Number of holders
- 130
- Value change
- +$1,018,038
- Number of buys
- 59
- Number of sells
- 46
- Shares outstanding
- 353,007,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
130
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patient Capital Managemen...
Disclosed value leader
Patient Capital Managemen...
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
Patient Capital Management, LLC leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patient Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Patient Capital Management, LLC
5.1%
ADAGE CAPITAL PARTNERS GP, L.L.C.
3.1%
BlackRock, Inc.
2.9%
VANGUARD GROUP INC
2.4%
IRIDIAN ASSET MANAGEMENT LLC/CT
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patient Capital Management, LLC |
13F
Company
|
5.1%
|
$16,988,789
17,937,694 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3.1%
|
$10,290,625
10,865,405 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
2.9%
|
$9,820,003
10,368,497 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.4%
|
$7,886,749
8,328,141 shares
|
— | 30 Sep 2024 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
1.1%
|
$3,576,212
3,775,960 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.92%
|
$3,075,089
3,246,508 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
130
Shares
75,787,342
Rows available
130
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
123
Q4 2024 holders
130
Holder diff
7
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend